Alice K. Jacobs, MD
Professor
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, Saint Louis University



A professor of medicine and the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston Medical Center, has been very involved in the American Heart Association. On a national level at the AHA, she is currently President -Elect, chair of the Professional Education Committee, a member of the Science Advisory Coordinating Committee and chair of the Council on Clinical Cardiology Program Committee. She is also involved in local AHA activities and currently serves as President of the Northeast Affiliate. In addition, Dr. Jacobs plays an active role in the American College of Cardiology. She has been a member of several ACC writing groups establishing training criteria in interventional cardiology, assessing and maintaining competence in interventional cardiology and updating guidelines for the performance of percutaneous coronary intervention. In addition, she is a member of the American Board of Internal Medicine Interventional Cardiology Test Committee and the ACC/AHA Task Force on Practice Guidelines. Dr. Jacobs' major research activities are in the area of invasive cardiology and revascularization strategies. Currently she is the site principal investigator of several multi-center trials including the NHLBI funded BARI 2-D, SHOCK, and OAT trials and the NHLBI Dynamic Registry. She is also active in the area of heart disease in women and has evaluated the acute and long-term outcomes of percutaneous coronary intervention in women in comparison to men.

Expertise includes: Interventional Cardiology; Coronary revascularization; Sex-based differences in cardiovascular disease.

2011-2011 LUMEN Conference: Recognition for advancing the care of patients with STEMI


A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment...
08/22/2013 - 12/31/2018 (PI)
Abbott Laboratories


A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous c
05/01/2010 - 04/30/2015 (PI)
Harvard Clinical Research Institute


Gravitas: Gauging Responsivness with a Verify Now Assay-Impact on Thrombsis and Safety
10/01/2008 - 09/30/2012 (PI)
Accumetrics


Xience V Everolimus Eluting Coronary Stent System Post-Approval Study (EECSS)
09/01/2008 - 05/31/2012 (PI)
Abbott Laboratories


Tilarginine Acetate Injection in a Randomized International Study in Unstable AMI Patients / Cardiogenic Shock
07/01/2005 - 06/30/2007 (PI)
Arginox

D.E.S. Cover Registry
04/13/2005 - 04/12/2007 (PI)
Cordis Corporation

The GUARD Trial Saphenous Vein Graft Intervention Using AngioGuard for Reduction of Distal Embolization
11/29/2000 - 12/31/2005 (PI)
Cordis Corporation

Clopidogrel for Reduction of Events During Observation (CREDO)
08/25/2000 - 08/31/2001 (PI)
Sanofi Pharmaceuticals Inc (from Cleveland Clinic Foundation) Bristol-Myers Squibb

XaNADU PCI Pilot Trial
01/22/2001 - 05/31/2001 (PI)
Duke University


Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
06/01/2015 - 05/31/2018 (PI)
Duke University Astrazeneca Pharmace

SILVER-AMI : Risk Stratification in Older Persons with Acute Myocardial Infarction
06/01/2013 - 05/31/2018 (PI)
Yale University NIH-NHLBI
5R01HL115295-04

MASS COMM Trial
08/30/2006 - 06/30/2014 (PI)
Harvard Clinical Research Institute DPH

VIRGO study
04/01/2009 - 05/01/2014 (PI)
Yale University NIH-NHLBI
R01 HL081153

Occluded Artery Trial (OAT)
02/01/2001 - 12/31/2010 (PI)
New York University DHHS
U01 HL62509

Bari 2 Diabetes (BARI 2D) Data Coordinating Center
01/01/2001 - 09/30/2010 (PI)
University of Pittsburgh DHHS
5 U01 HL61744-03

FREEDOM (Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management
06/22/2006 - 12/31/2007 (PI)
Mount Sinai Medical Center NIH-NHLBI
1 R01 HL 071988-01A1

SHOCK II Phase 2 Trial
11/01/2003 - 10/30/2005 (PI)
Arginox Pharmaceuticals NIH-NHLBI

Mechanisms Of Pro Thrombosis I
07/01/2001 - 06/30/2005 (PI)
University of Vermont NIH-NHLBI
1R01HL6914601


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Jacobs AK, Pande AN. Revascularization for Stable Ischemic Heart Disease: The Courage to Use What We Have Learned. JACC Cardiovasc Interv. 2018 May 14; 11(9):876-878.View Related Profiles. PMID: 29747918.
     
  2. Green JL, Jacobs AK, Holmes D, Chiswell K, Blanco R, Bates ER, French W, Kupas DF, Mears G, Roe M, Nallamothu BK. Taking the Reins on Systems of Care for ST-Segment-Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2018 May; 11(5):e005706. PMID: 29716933.
     
  3. Hannan EL, Samadashvili Z, Cozzens K, Berger PB, Chikwe J, Jacobs AK, Walford G, Ling FSK, Venditti FJ, Gold J, King SB. 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings. JACC Cardiovasc Interv. 2018 Mar 12; 11(5):473-478. PMID: 29519380.
     
  4. Levine GN, Dai X, Henry TD, Calfon Press M, Denktas AE, Garberich RF, Jacobs AK, Jaski BE, Kaul P, Kontos MC, Stouffer GA, Smith SC. In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment. JAMA Cardiol. 2018 Feb 21. PMID: 29466558.
     
  5. Hannan EL, Zhong Y, Berger PB, Jacobs AK, Walford G, Ling FSK, Venditti FJ, King SB. Association of Coronary Vessel Characteristics With Outcome in Patients With Percutaneous Coronary Interventions With Incomplete Revascularization. JAMA Cardiol. 2018 Feb 01; 3(2):123-130. PMID: 29282471.
     
  6. Langabeer JR, Henry TD, Fowler R, Champagne-Langabeer T, Kim J, Jacobs AK. Sex-Based Differences in Discharge Disposition and Outcomes for ST-Segment Elevation Myocardial Infarction Patients Within a Regional Network. J Womens Health (Larchmt). 2018 Jan 10. PMID: 29319393.
     
  7. Koshy LM, Aberle LH, Krucoff MW, Hess CN, Mazzaferri E, Jolly SS, Jacobs A, Gibson CM, Mehran R, Gilchrist IC, Rao SV. Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention. J Invasive Cardiol. 2018 01; 30(1):18-22. PMID: 29035844.
     
  8. van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, Thiele H, Washam JB, Cohen MG. Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association. Circulation. 2017 Oct 17; 136(16):e232-e268. PMID: 28923988.
     
  9. Hannan EL, Samadashvili Z, Cozzens K, Gesten F, Osinaga A, Fish DG, Donahue CL, Bass RJ, Walford G, Jacobs AK, Venditti FJ, Stamato NJ, Berger PB, Sharma S, King SB. Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria. J Am Coll Cardiol. 2017 Mar 14; 69(10):1234-1242. PMID: 28279289; DOI: 10.1016/j.jacc.2016.12.025;.
     
  10. Hannan EL, Zhong Y, Cozzens K, Gesten F, Friedrich M, Berger PB, Jacobs AK, Walford G, Ling FS, Venditti FJ, King SB. The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting. JACC Cardiovasc Interv. 2017 Feb 13; 10(3):224-231. PMID: 28183462; DOI: 10.1016/j.jcin.2016.10.040;.
     
Showing 10 of 352 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 342 publications over 37 distinct years, with a maximum of 28 publications in 2006

YearPublications
19813
19821
19841
19853
19861
19872
19882
19895
19903
19917
199210
19931
19945
19954
19962
19975
19984
199912
20006
200117
200218
200316
200418
200513
200628
200720
200812
200911
201014
201120
201216
201318
201415
201510
20168
20175
20186
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

acute coronary syndromes
angioplasty, percutaneous transluminal
coronary artery disease
Contact for Mentoring:


88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map


Jacobs's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department